FBP2
Fructose-1,6-bisphosphatase isozyme 2
Also known as: F16P2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00757
- Gene
- FBP2
- Ensembl
- ENSG00000130957
- Chromosome
- 9
- Canonical length
- 339 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a gluconeogenesis regulatory enzyme which catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
339 residues, UniProt reviewed canonical sequence.
>O00757|FBP2
1 MTDRSPFETD MLTLTRYVME KGRQAKGTGE LTQLLNSMLT AIKAISSAVR KAGLAHLYGI
61 AGSVNVTGDE VKKLDVLSNS LVINMVQSSY STCVLVSEEN KDAIITAKEK RGKYVVCFDP
121 LDGSSNIDCL ASIGTIFAIY RKTSEDEPSE KDALQCGRNI VAAGYALYGS ATLVALSTGQ
181 GVDLFMLDPA LGEFVLVEKD VKIKKKGKIY SLNEGYAKYF DAATTEYVQK KKFPEDGSAP
241 YGARYVGSMV ADVHRTLVYG GIFLYPANQK SPKGKLRLLY ECNPVAYIIE QAGGLATTGT
301 QPVLDVKPEA IHQRVPLILG SPEDVQEYLT CVQKNQAGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FBP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 706 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 706 nTPM
- tongue: 360 nTPM
- choroid plexus: 217 nTPM
- parathyroid gland: 47 nTPM
- stomach: 34 nTPM
- esophagus: 7.7 nTPM
Single-cell type
- choroid plexus epithelial cells: 192 nCPM
- myonuclei: 88 nCPM
- gastric chief cells: 69 nCPM
- mucous neck cells: 37 nCPM
- oocytes: 37 nCPM
- parietal cells: 16 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 156 nTPM
- hippocampal formation: 13 nTPM
- thalamus: 2.9 nTPM
- cerebellum: 2.5 nTPM
- spinal cord: 2.3 nTPM
- medulla oblongata: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FBP2.
Disease | AllUniProt
Conditions FBP2 is implicated in, by any mechanism.
- Leukodystrophy, childhood-onset, remitting (CORLK) MIM:619864
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fructose 1,6-bisphosphate metabolic process
- fructose 6-phosphate metabolic process
- fructose metabolic process
- gluconeogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FBP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FBP2 as an antibody target. Whether an autoantibody or antibody against FBP2 could matter depends on whether native FBP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FBP2 is annotated at the cell surface, where native FBP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FBP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...